Entrada Therapeutics Announces Recipients of Third Annual DREAMS Grant Program
Provided By GlobeNewswire
Last update: Sep 5, 2025
-- The 2025 DREAMS Grant Program awards $50,000 each to two non-profit organizations working to advance equity, accessibility and inclusion for those living with Duchenne in the U.S., EU or U.K. --
Read more at globenewswire.com
